Skip to main content

Cyclandelate

  • Chapter
  • First Online:

Abstract

Cyclandelate is extracted from almond, which is a kind of nut from Xinjiang, China. Traditional Chinese medicine believes that almond can promote blood circulation to dispel blood stasis, lubricate bowels to relieve constipation, and relieve cough and asthma. The chemical structure and effect of cyclandelate are similar to papaverine. It can directly relax vascular smooth muscle and relieve the spasm of ileum and uterus smooth muscle induced by acetylcholine, histamine, and barium chloride in guinea pig. This effect is three to five times stronger than papaverine. It was reported that cyclandelate can promote the collateral circulation but has little effect on respiration, blood pressure, cardiac output, and myocardial oxygen consumption. It is safe for long-term administration. Cyclandelate can be used for clinical treatment of cerebral arteriosclerosis, cerebral vascular accident and its sequelae, post-traumatic brain syndrome, coronary arteriosclerosis, hypertensive heart disease, Raynaud’s disease, thromboangiitis obliterans, acrocyanosis, and Meniere’s disease. However, cyclandelate has not yet been approved by the Food and Drug Administration in the United States, Canada, and other countries because it easily causes white blood cell deficiency. It has been withdrawn from the market after drug approval in Japan, France, and other countries in the 1970s.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Funcke AB, Ernsting MJ, Rekker RF, Nauta WT. Studies of spasmolytics. I. Mandelic acid esters. Arzneimittelforschung. 1953;3(10):503–6.

    CAS  PubMed  Google Scholar 

  2. Diener HC, Krupp P, Schmitt T, Steitz G, Milde K, Freytag S. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia. 2001;21(1):66–70.

    Article  CAS  Google Scholar 

  3. Cameron BD, et al. The metabolic fate of the coronary vasodilator 4-(3,4,5-Trimethoxycinnamoyl)-1-(N-pyrrolidinocarbonylmethyl)piperazine (cinepazide) in the rat, dog and man[J]. Xenobiotica. 1976;6(7):441–55.

    Article  CAS  Google Scholar 

  4. Laporte JR, Capellà D, Juan J. Agranulocytosis induced by cinepazide. Eur J Clin Pharmacol. 1990;38(4):387–8.

    Article  CAS  Google Scholar 

  5. Takeda M, Tanaka T, Okochi M. New drugs for Alzheimer’s disease in Japan. Psychiatry Clin Neurosci. 2011;65(5):399–404.

    Article  CAS  Google Scholar 

  6. Sidney M. Wolfe, M.D. Differences in the number of drug safety withdrawals: United States, United Kingdom, Germany and France 1970–1992. Drug Safety Withdrawals 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guan-Hua Du .

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ma, YZ., Qiang, GF., Du, GH. (2018). Cyclandelate. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_37

Download citation

Publish with us

Policies and ethics